Cargando…

A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease

INTRODUCTION: A straightforward, reproducible blood-based test that predicts age-dependent risk of Alzheimer's disease (AD) could be used as an enrichment tool for clinical development of therapies. This study evaluated the prognostic performance of a genetics-based biomarker risk algorithm (GB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lutz, Michael W., Sundseth, Scott S., Burns, Daniel K., Saunders, Ann M., Hayden, Kathleen M., Burke, James R., Welsh-Bohmer, Kathleen A., Roses, Allen D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817110/ https://www.ncbi.nlm.nih.gov/pubmed/27047990 http://dx.doi.org/10.1016/j.trci.2015.12.002

Ejemplares similares

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
por: Burns, Daniel K., et al.
Publicado: (2019)

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
por: Roses, A D, et al.
Publicado: (2010)

Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level–dependent functional magnetic resonance imaging study in elderly adults
por: Knodt, Annchen R., et al.
Publicado: (2019)

Characterization of APOE and TOMM40 allele frequencies in the Japanese population
por: Nishimura, Akira, et al.
Publicado: (2017)

TOMMORROW neuropsychological battery: German language validation and normative study
por: Romero, Heather R., et al.
Publicado: (2018)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease
por: Schott, Jonathan M., et al.
Publicado: (2016)

Alzheimer’s disease: diagnostics, prognostics and the road to prevention
por: Grossman, Iris, et al.
Publicado: (2010)

Genetically Modified Corn— Environmental Benefits and Risks
por: Gewin, Virginia
Publicado: (2003)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's disease
por: Anstey, Kaarin J., et al.
Publicado: (2015)

Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study
por: Bhattacharjee, Sandipan, et al.
Publicado: (2019)

APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans
por: Yu, Lei, et al.
Publicado: (2017)

Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease
por: Hendrix, Suzanne B, et al.
Publicado: (2013)

A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease
por: Lopatko Lindman, Karin, et al.
Publicado: (2019)

Enhancing Nurse Manager Resilience in a Pandemic
por: Carter, Megan, et al.
Publicado: (2021)

Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses
por: Wood, Laura S., et al.
Publicado: (2022)

Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations
por: Linnertz, Colton, et al.
Publicado: (2012)

Leading Our Frontline HEROES Through Times of Crisis With a Sense of Hope, Efficacy, Resilience, and Optimism
por: Dimino, Kimberly, et al.
Publicado: (2020)

The problem with risk
por: Jones, Dan
Publicado: (2020)

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
por: Simrén, Joel, et al.
Publicado: (2021)

Measuring outcomes of a successful mentoring dyad: A case study to optimize resources
por: Caruso, Judith T., et al.
Publicado: (2021)

Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
por: Langlois, Carolyn M., et al.
Publicado: (2019)

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
por: Verberk, Inge M. W., et al.
Publicado: (2021)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Analysis of high‐risk pedigrees identifies 11 candidate variants for Alzheimer's disease
por: Teerlink, Craig C., et al.
Publicado: (2021)

Telomere length associations with cognition depend on Alzheimer's disease biomarkers
por: Mahoney, Emily R., et al.
Publicado: (2019)

Forecasting the progression of Alzheimer's disease using neural networks and a novel preprocessing algorithm
por: Albright, Jack
Publicado: (2019)

General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women
por: Petkus, Andrew J., et al.
Publicado: (2019)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non‐hypertensive Alzheimer's patients
por: Al‐Hamed, Faez Saleh, et al.
Publicado: (2021)

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
por: Evans, Stephanie, et al.
Publicado: (2019)

Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
por: Libiger, Ondrej, et al.
Publicado: (2021)

Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
por: Disbrow, Elizabeth, et al.
Publicado: (2021)

Co-twin design in brain imaging—review on biomarkers of Alzheimer's disease
por: Varjonen, Anni, et al.
Publicado: (2023)

The role of collective labor contracts and individual characteristics on job satisfaction in Tuscan nursing homes
por: Vainieri, Milena, et al.
Publicado: (2019)

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
por: Izzo, Nicholas J., et al.
Publicado: (2021)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
por: Delaby, Constance, et al.
Publicado: (2021)

Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
por: Taylor, Matthew K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2gsipnvaub1b77rd8ig2vpnode